{
 "Susceptible": {
 "Drug": {
 "Cefoxitin": {
 "State": {
 "State": [ "N/A" ],
"percentage": [      100 ] 
},
"Gender": {
 "Gender": [ "Female", "Male" ],
"percentage": [       50,       50 ] 
},
"Age.Group": {
 "Age.Group": [ "19 to 64 Years", "65 to 84 Years" ],
"percentage": [       75,       25 ] 
},
"Speciality": {
 "Speciality": [ "Medicine General", "None Given", "Surgery General" ],
"percentage": [       25,       25,       50 ] 
},
"Source": {
 "Source": [ "Bodily Fluids: Abscess / Pus", "GI: Gall Bladder", "INT: Wound" ],
"percentage": [       25,       25,       50 ] 
},
"In...Out.Patient": {
 "In...Out.Patient": [ "Inpatient", "None Given" ],
"percentage": [       75,       25 ] 
} 
},
"Clindamycin": {
 "State": {
 "State": [ "N/A" ],
"percentage": [      100 ] 
},
"Gender": {
 "Gender": [ "Female" ],
"percentage": [      100 ] 
},
"Age.Group": {
 "Age.Group": [ "19 to 64 Years" ],
"percentage": [      100 ] 
},
"Speciality": {
 "Speciality": [ "Surgery General" ],
"percentage": [      100 ] 
},
"Source": {
 "Source": [ "Bodily Fluids: Abdominal" ],
"percentage": [      100 ] 
},
"In...Out.Patient": {
 "In...Out.Patient": [ "Inpatient" ],
"percentage": [      100 ] 
} 
},
"Meropenem": {
 "State": {
 "State": [ "N/A" ],
"percentage": [      100 ] 
},
"Gender": {
 "Gender": [ "Female", "Male" ],
"percentage": [       60,       40 ] 
},
"Age.Group": {
 "Age.Group": [ "19 to 64 Years", "65 to 84 Years" ],
"percentage": [       80,       20 ] 
},
"Speciality": {
 "Speciality": [ "Medicine General", "None Given", "Surgery General" ],
"percentage": [       20,       20,       60 ] 
},
"Source": {
 "Source": [ "Bodily Fluids: Abdominal", "Bodily Fluids: Abscess / Pus", "GI: Gall Bladder", "INT: Wound" ],
"percentage": [       20,       20,       20,       40 ] 
},
"In...Out.Patient": {
 "In...Out.Patient": [ "Inpatient", "None Given" ],
"percentage": [       80,       20 ] 
} 
},
"Metronidazole": {
 "State": {
 "State": [ "N/A" ],
"percentage": [      100 ] 
},
"Gender": {
 "Gender": [ "Female", "Male" ],
"percentage": [       60,       40 ] 
},
"Age.Group": {
 "Age.Group": [ "19 to 64 Years", "65 to 84 Years" ],
"percentage": [       80,       20 ] 
},
"Speciality": {
 "Speciality": [ "Medicine General", "None Given", "Surgery General" ],
"percentage": [       20,       20,       60 ] 
},
"Source": {
 "Source": [ "Bodily Fluids: Abdominal", "Bodily Fluids: Abscess / Pus", "GI: Gall Bladder", "INT: Wound" ],
"percentage": [       20,       20,       20,       40 ] 
},
"In...Out.Patient": {
 "In...Out.Patient": [ "Inpatient", "None Given" ],
"percentage": [       80,       20 ] 
} 
},
"Piperacillin tazobactam": {
 "State": {
 "State": [ "N/A" ],
"percentage": [      100 ] 
},
"Gender": {
 "Gender": [ "Female", "Male" ],
"percentage": [       60,       40 ] 
},
"Age.Group": {
 "Age.Group": [ "19 to 64 Years", "65 to 84 Years" ],
"percentage": [       80,       20 ] 
},
"Speciality": {
 "Speciality": [ "Medicine General", "None Given", "Surgery General" ],
"percentage": [       20,       20,       60 ] 
},
"Source": {
 "Source": [ "Bodily Fluids: Abdominal", "Bodily Fluids: Abscess / Pus", "GI: Gall Bladder", "INT: Wound" ],
"percentage": [       20,       20,       20,       40 ] 
},
"In...Out.Patient": {
 "In...Out.Patient": [ "Inpatient", "None Given" ],
"percentage": [       80,       20 ] 
} 
},
"Tigecycline": {
 "State": {
 "State": [ "N/A" ],
"percentage": [      100 ] 
},
"Gender": {
 "Gender": [ "Female", "Male" ],
"percentage": [       50,       50 ] 
},
"Age.Group": {
 "Age.Group": [ "19 to 64 Years", "65 to 84 Years" ],
"percentage": [       75,       25 ] 
},
"Speciality": {
 "Speciality": [ "Medicine General", "None Given", "Surgery General" ],
"percentage": [       25,       25,       50 ] 
},
"Source": {
 "Source": [ "Bodily Fluids: Abscess / Pus", "GI: Gall Bladder", "INT: Wound" ],
"percentage": [       25,       25,       50 ] 
},
"In...Out.Patient": {
 "In...Out.Patient": [ "Inpatient", "None Given" ],
"percentage": [       75,       25 ] 
} 
} 
},
"percentage": [ 16.66667, 4.166667, 20.83333, 20.83333, 20.83333, 16.66667 ],
"weight":      0.8,
"backgroundColor": [ "#e31a1c", "#6a3d9a", "#bebada", "#fb8072", "#b3de69", "#fccde5" ] 
},
"Intermediate": {
 "Drug": {
 "Cefoxitin": {
 "State": {
 "State": [ "N/A" ],
"percentage": [      100 ] 
},
"Gender": {
 "Gender": [ "Female" ],
"percentage": [      100 ] 
},
"Age.Group": {
 "Age.Group": [ "19 to 64 Years" ],
"percentage": [      100 ] 
},
"Speciality": {
 "Speciality": [ "Surgery General" ],
"percentage": [      100 ] 
},
"Source": {
 "Source": [ "Bodily Fluids: Abdominal" ],
"percentage": [      100 ] 
},
"In...Out.Patient": {
 "In...Out.Patient": [ "Inpatient" ],
"percentage": [      100 ] 
} 
},
"Tigecycline": {
 "State": {
 "State": [ "N/A" ],
"percentage": [      100 ] 
},
"Gender": {
 "Gender": [ "Female" ],
"percentage": [      100 ] 
},
"Age.Group": {
 "Age.Group": [ "19 to 64 Years" ],
"percentage": [      100 ] 
},
"Speciality": {
 "Speciality": [ "Surgery General" ],
"percentage": [      100 ] 
},
"Source": {
 "Source": [ "Bodily Fluids: Abdominal" ],
"percentage": [      100 ] 
},
"In...Out.Patient": {
 "In...Out.Patient": [ "Inpatient" ],
"percentage": [      100 ] 
} 
} 
},
"percentage": [       50,       50 ],
"weight": 0.06666667,
"backgroundColor": [ "#e31a1c", "#fccde5" ] 
},
"Resistant": {
 "Drug": {
 "Clindamycin": {
 "State": {
 "State": [ "N/A" ],
"percentage": [      100 ] 
},
"Gender": {
 "Gender": [ "Female", "Male" ],
"percentage": [       50,       50 ] 
},
"Age.Group": {
 "Age.Group": [ "19 to 64 Years", "65 to 84 Years" ],
"percentage": [       75,       25 ] 
},
"Speciality": {
 "Speciality": [ "Medicine General", "None Given", "Surgery General" ],
"percentage": [       25,       25,       50 ] 
},
"Source": {
 "Source": [ "Bodily Fluids: Abscess / Pus", "GI: Gall Bladder", "INT: Wound" ],
"percentage": [       25,       25,       50 ] 
},
"In...Out.Patient": {
 "In...Out.Patient": [ "Inpatient", "None Given" ],
"percentage": [       75,       25 ] 
} 
} 
},
"percentage":      100,
"weight": 0.1333333,
"backgroundColor": "#6a3d9a" 
} 
}
